Robert Pollock
Clinical Pathology · Orlando, FLNPI 1538148572
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $261,493 of the $263,658 with a category attached, or 99.2%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 84.1% of it on its own, with 2 other manufacturers making up the rest.
Across 168 payments — averaging $1569.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$222K
- Shire North American Group Inc$42K
- RARE Disease Therapeutics, Inc.$15
What the payments were for
- Consulting fees$261,49399%
- Travel & lodging$2,1491%
- Food & beverage$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 145 | $221,696 |
| Shire North American Group Inc | 22 | $41,947 |
| RARE Disease Therapeutics, Inc. | 1 | $15 |
How this compares
Too few clinical pathology providers in Floridato place this figure against a meaningful peer group, so we don't.
Other clinical pathology in Orlando
- Austin BelknapOrlando$119
- Pedro CanoTampa$33K
- Unknown AlnoorMiami$2K
- Joseph SchwartzTampa$371
- Wilfredo BlasiniFort Myers$279
- Patrick ErdmanTampa$274
- Christian WunschMiami$235
- Robert StappTampa$123
- Nicole EspositoTampa$88
- James SpencerSarasota$61
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.